ALRS vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALRS exhibits weak financial health with a Piotroski F-Score of 4/9, indicating marginal stability, and lacks an Altman Z-Score, raising unquantified distress risk. The stock trades at a high forward P/E of 8.54 but has a current P/E of 34.65, suggesting overvaluation relative to near-term earnings. Despite strong earnings surprises in recent quarters and a 93.2% YoY EPS growth, the company reports a negative operating margin of -481.44% and an 85.8% revenue decline, signaling severe operational distress. The dividend payout ratio of 122.06% is unsustainable, and technical trends are bearish, reinforcing caution. The Graham Number of $18.44 implies a defensive fair value below the current price of $23.56.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ALRS vs JPM: Head-to-Head Comparison
This page compares Alerus Financial Corporation (ALRS) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.